Send Message
Home > products > Anti-Tumor > Pralatrexate (52853-40-4)

Pralatrexate (52853-40-4)

Product:
Pralatrexate
Description:
CAS: 52853-40-4; anti-tumor ; pralatrexate t cell lymphoma
Category:
Anti-Tumor
In-stock:
In Stock
Payment Method:
L/C, T/T
Shipping Method:
AIR, Express
Specifications
CAS:
52853-40-4
Specification:
CP, EP, In-house, As Required
M.F.:
C23H23N7O5
M.W.:
477.47
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
High Light:

Pralatrexate 52853-40-4

,

anti tumor pralatrexate t cell lymphoma

,

CAS: 52853-40-4 pralatrexate t cell lymphoma

Introduction

Pralatrexate, an injectable DHFR inhibitor, was launched for the treatment of patients with relapsed or refractory PTCL. The inhibition of the folate enzymes DHFR and thymidylate synthase is a well-validated method of cancer treatment.

 

Pralatrexate (52853-40-4) 0

 

Product Name: Pralatrexate
CAS No.: 52853-40-4
Assay: 989%
Specification: CP, EP, In-house, as required
Molecular Formula: C23H23N7O5
Molecular Weight: 477.47
Shelf Life: 2 Years
Package: 25kg/drum

 

 

Pralatrexate (52853-40-4) 1

Pralatrexate (52853-40-4) 2

Pralatrexate (52853-40-4) 3

Send RFQ
Stock:
In Stock
MOQ: